These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1223 related articles for article (PubMed ID: 28810875)
1. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y; Qin N; Zhou Q; Chen Y; Huang S; Chen B; Shen G; Jia H J Transl Med; 2017 Aug; 15(1):176. PubMed ID: 28810875 [TBL] [Abstract][Full Text] [Related]
2. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054 [TBL] [Abstract][Full Text] [Related]
3. Actin-like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial-mesenchymal transition. Xiao S; Chang RM; Yang MY; Lei X; Liu X; Gao WB; Xiao JL; Yang LY Hepatology; 2016 Apr; 63(4):1256-71. PubMed ID: 26698646 [TBL] [Abstract][Full Text] [Related]
4. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma. Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856 [TBL] [Abstract][Full Text] [Related]
5. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells. Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of brachyury contributes to tumor metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma. Du R; Wu S; Lv X; Fang H; Wu S; Kang J J Exp Clin Cancer Res; 2014 Dec; 33(1):105. PubMed ID: 25499255 [TBL] [Abstract][Full Text] [Related]
7. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
9. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression. Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-630 suppresses tumor metastasis through the TGF-β- miR-630-Slug signaling pathway and correlates inversely with poor prognosis in hepatocellular carcinoma. Chen WX; Zhang ZG; Ding ZY; Liang HF; Song J; Tan XL; Wu JJ; Li GZ; Zeng Z; Zhang BX; Chen XP Oncotarget; 2016 Apr; 7(16):22674-86. PubMed ID: 26993767 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
12. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition. Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
14. KIAA1217 Promotes Epithelial-Mesenchymal Transition and Hepatocellular Carcinoma Metastasis by Interacting with and Activating STAT3. Wang Y; Li N; Zheng Y; Wang A; Yu C; Song Z; Wang S; Sun Y; Zheng L; Wang G; Liu L; Yi J; Huang Y; Zhang M; Bao Y; Sun L Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008530 [TBL] [Abstract][Full Text] [Related]
15. Programmed cell death 10 promotes metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma via PP2Ac-mediated YAP activation. Sun B; Zhong FJ; Xu C; Li YM; Zhao YR; Cao MM; Yang LY Cell Death Dis; 2021 Sep; 12(9):849. PubMed ID: 34521817 [TBL] [Abstract][Full Text] [Related]
16. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
17. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy. Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107 [TBL] [Abstract][Full Text] [Related]
18. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA UC001kfo promotes hepatocellular carcinoma proliferation and metastasis by targeting α-SMA. Pan Y; Qin T; Yin S; Zhang X; Gao X; Mu L Biomed Pharmacother; 2017 Mar; 87():669-677. PubMed ID: 28088733 [TBL] [Abstract][Full Text] [Related]
20. Silencing of GP73 inhibits invasion and metastasis via suppression of epithelial-mesenchymal transition in hepatocellular carcinoma. Yang Y; Liu Q; Zhang H; Zhao H; Mao R; Li Z; Ya S; Jia C; Bao Y Oncol Rep; 2017 Feb; 37(2):1182-1188. PubMed ID: 28075476 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]